{
    "clinical_study": {
        "@rank": "112634", 
        "arm_group": [
            {
                "arm_group_label": "300ml tap water", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Single intragastric instillation of 300ml tap water via nasogastric tube"
            }, 
            {
                "arm_group_label": "Glucose", 
                "arm_group_type": "Active Comparator", 
                "description": "Single intragastric instillation of 75g Glucose in 300ml tap water via nasogastric tube"
            }, 
            {
                "arm_group_label": "Glucose plus Lactisole", 
                "arm_group_type": "Active Comparator", 
                "description": "Single intragastric instillation of 75g Glucose in 300ml tap water with 450ppm lactisole"
            }, 
            {
                "arm_group_label": "Fructose", 
                "arm_group_type": "Active Comparator", 
                "description": "Single intragastric instillation of 25g Fructose in 300ml tap water via nasogastric tube"
            }, 
            {
                "arm_group_label": "Glucose and Exendin", 
                "arm_group_type": "Active Comparator", 
                "description": "Single intragastric instillation of 75g glucose in 300ml tap water with 600pmol/kg/min exendin 9-39"
            }, 
            {
                "arm_group_label": "tap water, lactisole", 
                "arm_group_type": "Sham Comparator", 
                "description": "Single intragastric instillation of 300ml tap water with 450ppm lactisole"
            }
        ], 
        "brief_summary": {
            "textblock": "Our objective is to investigate neuro-anatomical correlates of the regulation of energy\n      intake by means of functional MRI. Administration of glucose with and without lactisole and\n      exendin as well as fructose is followed by functional brain MRI, and findings are correlated\n      with serum GLP-1 levels as an endogenous satiety signal in humans."
        }, 
        "brief_title": "The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Exploratory Behavior", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  right-handed healthy males, no drugs, non-smoking\n\n        Exclusion Criteria:\n\n          -  drug abuse, smoker, left-handed, claustrophobia"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01918566", 
            "org_study_id": "EKBB 298/12"
        }, 
        "intervention": [
            {
                "arm_group_label": "300ml tap water", 
                "intervention_name": "tap water", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Glucose", 
                "intervention_name": "Single intragastric instillation of 75g Glucose in 300ml tap water via nasogastric tube", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Glucose plus Lactisole", 
                "intervention_name": "Single intragastric instillation of 75g Glucose in 300ml tap water with 450ppm lactisole", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Fructose", 
                "intervention_name": "25g Fructose in 300ml tap water", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Glucose and Exendin", 
                "intervention_name": "75g glucose in 300ml tap water with 600pmol/kg/min exendin 9-39", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "tap water, lactisole", 
                "intervention_name": "300ml tap water with 450ppm lactisole", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Basel", 
                    "country": "Switzerland", 
                    "zip": "CH-4031"
                }, 
                "name": "University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "6", 
        "official_title": "The Role of Endogenous GLP-1 in Regulating Glucose Stimulated Brain Activity", 
        "overall_official": {
            "affiliation": "University Hospital, Basel, Switzerland", 
            "last_name": "Christoph Beglinger, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Whole brain analysis with a cluster-level threshold was followed by an a priori defined region of interest analysis of the dorsolateral prefrontal cortex including a cluster-level threshold and family-wise error adjustment for multiple comparisons.", 
            "measure": "Functional magnetic resonance imaging (fMRI) in healthy volunteers while they performed a working memory task: changes in cerebral blood flow and blood hormones from baseline to treatment", 
            "safety_issue": "No", 
            "time_frame": "changes from baseline to one hour after treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01918566"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Hospital, Basel, Switzerland", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Basel, Switzerland", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}